Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The assessee, incorporated under Canadian laws, rendered pre-clinical laboratory services to Indian customers in the pharmaceutical, medical device, and biotechnology industries. These services involved conducting in vitro and in vivo tests and trials to determine safe dosages and assess potential toxicity of new drugs before human clinical trials. The Indian customers provided samples for testing by the assessee. The Tribunal held that the pre-clinical laboratory services rendered by the assessee did not constitute "making available" technical knowledge, experience, skill, know-how, or processes to the Indian customers. The utility of the services was limited to a report, which did not independently transfer technological knowledge enabling the clients to conduct future clinical tests. The clients had to continuously refer to the assessee for understanding the report. Therefore, the receipts from such services did not qualify as Fees for Included Services (FIS) or Fees for Technical Services (FTS) under the India-Canada Tax Treaty.
The assessee, incorporated under Canadian laws, rendered pre-clinical laboratory services to Indian customers in the pharmaceutical, medical device, and biotechnology industries. These services involved conducting in vitro and in vivo tests and trials to determine safe dosages and assess potential toxicity of new drugs before human clinical trials. The Indian customers provided samples for testing by the assessee. The Tribunal held that the pre-clinical laboratory services rendered by the assessee did not constitute "making available" technical knowledge, experience, skill, know-how, or processes to the Indian customers. The utility of the services was limited to a report, which did not independently transfer technological knowledge enabling the clients to conduct future clinical tests. The clients had to continuously refer to the assessee for understanding the report. Therefore, the receipts from such services did not qualify as Fees for Included Services (FIS) or Fees for Technical Services (FTS) under the India-Canada Tax Treaty.
Note: It is a system-generated summary and is for quick reference only.